當前位置:首頁>學者列表>醫學院(FMD) >湯寧信>發佈文章列表[所有]
排序方式:
    總頁 40 
      Go

    1.Comparing rosuvastatin and atorvastatin on cardiovascular and kidney outcomes in patients with diabetes across chronic kidney disease stages: an emulated target trial in China

    Huang, YT, Yang, AM,     More...

    ECLINICALMEDICINE[2589-5370], Published 2026, Volume 91,

    收錄情况: WOS

    WOS核心合集引用:  2024影響因子:  10.0 

    2.Targeting APOC3 with Olezarsen in Moderate Hypertriglyceridemia.

    Tomlinson, Brian

    New England Journal of Medicine[0028-4793], Published 2026, Volume 394, Issue 1, Pages 99

    收錄情况: SCOPUS

    2024影響因子:  78.5 

    3.Targeting KAT8 alleviates vascular senescence by modulating the INHBA/TGF-β pathway

    Lin, Zhongxiao, Xion     More...

    Molecular Therapy[1525-0016], Published 2026,

    收錄情况: SCOPUS

    2024影響因子:  12.0 

    4.An up-to-date review of emerging biologic therapies for hypercholesterolemia

    Tomlinson, B

    EXPERT OPINION ON BIOLOGICAL THERAPY[1471-2598], Published 2025, Volume 25, Issue 1, Pages 69-78

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2024影響因子:  4.0 

    5.Exploring emerging pharmacotherapies for type 2 diabetes patients with hypertriglyceridemia

    Tomlinson, B, Chan,     More...

    EXPERT OPINION ON PHARMACOTHERAPY[1465-6566], Published 2025, Volume 26, Issue 3, Pages 279-289

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2024影響因子:  2.7 

    6.Cardiomyocyte Foxp1-Specific Deletion Promotes Post-injury Heart Regeneration via Targeting Usp20-HIF1α-Hand1 Signaling Pathway

    Wang, YF, Wang, XY,     More...

    ADVANCED SCIENCE[2198-3844], Published 2025, Volume 12, Issue 12,

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2024影響因子:  14.1 

    7.Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry

    Elshorbagy, A, Valle     More...

    EUROPEAN HEART JOURNAL[0195-668X], Published 2025, Volume 46, Issue 12, Pages 1127-1140

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 11  2024影響因子:  35.6 

    8.Systematic review of lipoprotein(a) levels in chinese subjects with and without atherosclerotic cardiovascular disease

    Tomlinson, B, Lao, U     More...

    ATHEROSCLEROSIS[0021-9150], Published 2025, Volume 407,

    收錄情况: WOS

    WOS核心合集引用:  2024影響因子:  5.7 

    9.Metformin in polycystic ovary syndrome: unraveling multi-stage therapeutic mechanisms from puberty to long-term health outcomes

    Zeng, WW, Luo, YN, O     More...

    FRONTIERS IN PHARMACOLOGY[1663-9812], Published 2025, Volume 16,

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2024影響因子:  4.8 

    10.Statin-Related Transaminitis-Is It Necessary to Stop Statins?

    Tomlinson, B, Zeng,     More...

    CARDIOVASCULAR DRUGS AND THERAPY[0920-3206], Published 2025,

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2024影響因子:  3.1 

    11.Antibody-Based Therapeutics for Hypercholesterolemia

    Tomlinson, B, Chan,     More...

    BIOLOGICS-TARGETS & THERAPY[1177-5475], Published 2025, Volume 19, Pages 631-649

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2024影響因子:  3.4 

    12.Global trends and health system impact on polycystic ovary syndrome: a comprehensive analysis of age-stratified females from 1990 to 2021

    Zeng, WW, Gan, DL, O     More...

    FRONTIERS IN REPRODUCTIVE HEALTH[2673-3153], Published 2025, Volume 7,

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2024影響因子:  2.9 

    13.Lipoprotein(a) - treatments in development

    Tomlinson, B, Law, C     More...

    EXPERT OPINION ON PHARMACOTHERAPY[1465-6566], Published 2025, Volume 26, Issue 17, Pages 1831-1839

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2024影響因子:  2.7 

    14.Advances in Dyslipidaemia Treatments: Focusing on ApoC3 and ANGPTL3 Inhibitors

    Tomlinson, Brian, Wu     More...

    Journal of Lipid and Atherosclerosis[2287-2892], Published 2024, Volume 13, Issue 1, Pages 2-20

    收錄情况: SCOPUS

    15.Circulating metabolomic markers linking diabetic kidney disease and incident cardiovascular disease in type 2 diabetes: analyses from the Hong Kong Diabetes Biobank

    Jin, Q, Lau, ESH, Lu     More...

    DIABETOLOGIA[0012-186X], Published 2024, Volume 67, Issue 5, Pages 837-849

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 15  2024影響因子:  10.2  发表年影響因子:  10.2 

    16.Genetic drivers of heterogeneity in type 2 diabetes pathophysiology

    Suzuki, K, Hatzikoto     More...

    NATURE[0028-0836], Published 2024, Volume 627, Issue 8003, Pages 347-357

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 265  2024影響因子:  48.5  发表年影響因子:  48.5 

    17.Effects of glucose-lowering drugs on cardiovascular outcomes in patients with type 2 diabetes: an update

    Tomlinson, B, Chan,     More...

    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY[1742-5255], Published 2024, Volume 20, Issue 4, Pages 175-179

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2024影響因子:  3.4  发表年影響因子:  3.4 

    18.The maximum dose of atorvastatin and simvastatin as well as rosuvastatin should be restricted in East Asians

    Tomlinson, B, Chow,     More...

    HONG KONG MEDICAL JOURNAL[1024-2708], Published 2024, Volume 30, Issue 2, Pages 184-185

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2024影響因子:  2.6  发表年影響因子:  2.6 

    19.Genetic factors related to aspirin resistance using the Multiplate® device in Hong Kong Chinese patients with stable coronary heart disease

    Zeng, WW, Chu, TTW,     More...

    HELIYON[2405-8440], Published 2024, Volume 10, Issue 14,

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2024影響因子:  3.6  发表年影響因子:  3.6 

    20.Therapeutic efficacy of ECs Foxp1 targeting Hif1α-Hk2 α-Hk2 glycolysis signal to restrict angiogenesis

    Pi, JJ, Chang, H, Ch     More...

    REDOX BIOLOGY[2213-2317], Published 2024, Volume 75,

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2024影響因子:  11.9  发表年影響因子:  11.9 

    顯示      條  合計  792  條
      總頁 40 
        Go

      本系統需要使用 Internet Explorer 9.0 以上Firefox || Chrome瀏覽器

      Copyright © 2018 澳門科技大學學者庫